$256 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 63 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | $8,074,000 | -6.8% | 72,441 | 0.0% | 3.15% | +3.1% | |
| STML | Stemline Therapeutics Inc | $7,517,000 | -2.2% | 492,930 | 0.0% | 2.93% | +8.2% | |
| INCY | Incyte Corp | $6,081,000 | -12.0% | 72,975 | 0.0% | 2.37% | -2.7% | |
| ALNY | Alnylam Pharmaceuticals Inc | $4,383,000 | -6.2% | 36,800 | 0.0% | 1.71% | +3.8% | |
| CLVS | Clovis Oncology Inc | $4,012,000 | -22.4% | 76,000 | 0.0% | 1.56% | -14.1% | |
| BLUE | Bluebird Bio Inc | $3,413,000 | -4.1% | 20,000 | 0.0% | 1.33% | +6.1% | |
| KALV | Kalvista Pharmaceuticals Inc | $3,008,000 | -4.1% | 322,436 | 0.0% | 1.17% | +6.1% | |
| AVXS | Avexis Inc | $2,100,000 | +11.6% | 17,000 | 0.0% | 0.82% | +23.5% | |
| SRPT | Sarepta Therapeutics Inc | $2,000,000 | +33.2% | 27,000 | 0.0% | 0.78% | +47.2% | |
| MTEM | Molecular Templates Inc | $1,978,000 | -20.1% | 247,587 | 0.0% | 0.77% | -11.6% | |
| CBAY | Cymabay Therapeutics Inc | $1,884,000 | +41.2% | 145,000 | 0.0% | 0.74% | +56.4% | |
| BGNE | BeiGene Ltdsponsored adr | $1,596,000 | +72.0% | 9,500 | 0.0% | 0.62% | +90.5% | |
| DCPH | Deciphera Pharmaceuticals Inc | $1,542,000 | -11.7% | 77,000 | 0.0% | 0.60% | -2.3% | |
| TRXC | Transenterix Inc | $1,503,000 | -12.0% | 889,082 | 0.0% | 0.59% | -2.7% | |
| FGEN | FibroGen Inc | $1,449,000 | -2.6% | 31,400 | 0.0% | 0.56% | +7.6% | |
| OPTN | Optinose Inc | $1,300,000 | +5.9% | 65,000 | 0.0% | 0.51% | +17.1% | |
| RSLS | ReShape Lifesciences Inc | $1,143,000 | -0.7% | 788,194 | 0.0% | 0.45% | +9.9% | |
| SBPH | Spring Bk Pharmaceuticals Inc | $1,091,000 | +14.1% | 73,000 | 0.0% | 0.43% | +26.4% | |
| GWPH | GW Pharmaceuticals Plcads | $1,082,000 | -14.6% | 9,600 | 0.0% | 0.42% | -5.6% | |
| HZNP | Horizon Pharma Plc | $979,000 | -2.8% | 69,000 | 0.0% | 0.38% | +7.6% | |
| SUPN | Supernus Pharmaceuticals Inc | $959,000 | +15.0% | 20,953 | 0.0% | 0.37% | +27.2% | |
| FOLD | Amicus Therapeutics Inc | $881,000 | +4.5% | 58,600 | 0.0% | 0.34% | +15.8% | |
| AERI | Aerie Pharmaceuticals Inc | $802,000 | -9.2% | 14,779 | 0.0% | 0.31% | +0.6% | |
| ONCE | Spark Therapeutics Inc | $799,000 | +29.5% | 12,000 | 0.0% | 0.31% | +43.1% | |
| PTLA | Portola Pharmaceuticals Inc | $784,000 | -32.9% | 24,000 | 0.0% | 0.31% | -25.7% | |
| RDUS | Radius Health Inc | $675,000 | +13.1% | 18,799 | 0.0% | 0.26% | +25.2% | |
| VKTX | Viking Therapeutics Inc | $305,000 | +7.4% | 70,000 | 0.0% | 0.12% | +19.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.